A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
Georgetown University
Georgetown University
Hackensack Meridian Health
M.D. Anderson Cancer Center
University of Chicago
University of Washington
Columbia University
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Dana-Farber Cancer Institute
University of California, San Diego
Weill Medical College of Cornell University
University of Miami
University of California, Davis
Memorial Sloan Kettering Cancer Center
German CLL Study Group
German CLL Study Group
Cedars-Sinai Medical Center
University of Rochester
University of Nebraska
Academic and Community Cancer Research United
University of Rochester
University of Giessen
University of Giessen
University of California, San Diego
City of Hope Medical Center
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
IRCCS San Raffaele
University of Nebraska
University of Nebraska
University of Wisconsin, Madison
Mayo Clinic
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Brown University
Gruppo Italiano Malattie EMatologiche dell'Adulto
University of Washington
Institute of Hematology & Blood Diseases Hospital, China
Weill Medical College of Cornell University
M.D. Anderson Cancer Center